AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. Ingle K, LaComb JF, Graves LM, Baines AT, et al. PLoS One 2023;18:e0294065.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ingle K, LaComb JF, Graves LM, Baines AT, et al. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. PLoS One 2023;18:e0294065.
PMID: 37943821